AzTrials
AzTrials

Blood Flow RestrictionNCT04977804

Eccentric Resistance Training With Blood Flow Restriction on Muscle Function

A study testing Exercise and Eccentric plus blood-flow restriction in people with Blood Flow Restriction, run by Utah State University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The study will determine the effects of adding blood flow restriction to eccentric training to assess whether this increases the improvements of muscle strength and size. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Blood Flow Restriction
What is being tested?
Exercise and Eccentric plus blood-flow restriction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
30 Mar 2024to 1 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-30 years of age
  • currently engaged in some form of resistance training between 1-3 times per week
  • must have been training aerobically, but no more than 3 hours a week for the past six months

Who cannot join

  • Must not have had any surgery of the lower limbs within the past 1 year period
  • Must not have any neuromuscular disorder (e.g., Muscular dystrophy etc.)
  • < 76 inches tall (in order to fit on the training machine)
  • Maximal strength of < 725 lbs for the eccentric training device
  • If any of the subjects are pregnant or plan to be pregnant in the duration of the protocol.
  • For those randomized to the BFR group, if any of the subject's thighs are too large for the BFR cuffs (greater than 68 cm).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Utah State Universtiy

    Logan, Utah, 84322

Other trials in United States

About this study

Official title: Effects of Blood Flow Restriction During Multiple-joint Eccentric Resistance Training on Muscle Morphology and Function of the Lower Body.

The study will determine the effects of adding blood flow restriction to eccentric training to assess whether this increases the improvements of muscle strength and size.

Read the detailed description

Subjects will be randomly assigned to two groups: an eccentric only resistance training group or an eccentric training plus blood flow restriction group. Subjects will train at a moderately low intensity on a multiple-joint eccentric device. Those in the blood flow restriction will wear blood flow restriction cuffs on their upper thighs to reduce blood flow during the brief protocol. The training session will occur twice per week and will last ~5 minutes, including a one minute warm up, a one minute cool down and a three minute workout phase. The training program will last 7 weeks. Testing will be conducted at baseline (following a one session familiarization), 4 weeks and after the end of the 7 week training period. Assessments will focus on muscle strength, function, and morphology (size).

Being tested
Exercise, Eccentric plus blood-flow restriction
Keywords
resistance training, muscle function, quadriceps, eccentric strength, vertical jump, muscle quality, muscle hypertrophy, eccentric training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    The interventions are a form or exercise, specifically resistance exercise.

  • Eccentric plus blood-flow restrictionOther

    Eccentric plus blood-flow restriction

Study groups in NCT04977804
Study groupRoleWhat they receive
Eccentric only trainingActive comparatorThis is the experimental control; where this group will be used as the standard active comparison condition.
Receives: Other: Exercise
Eccentric plus blood-flow restrictionExperimentalThis is the experimental condition involving the eccentric resistance training with blood flow restriction.
Receives: Other: Eccentric plus blood-flow restriction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eccentron maximal muscle strength

    Eccentric muscle strength will be assessed via Eccentron (BTE Technologies, Inc., USA), an seated isokinetic dynamometer.

    Measured: 7 weeks

  2. Local muscle hypertrophy

    Muscle size changes of the quadriceps muscle measured an ultrasound device (GE NextGen LOGIQ, Tampa, Florida, USA).

    Measured: 7 weeks

  3. Muscle mass

    dual energy x-ray absorptiometry device (DEXA) the Hologic Horizon W Dual X-ray absorptiometry (Hologic Canada ULC, Mississauga, ON, Canada) will be used to assess appendicular (lower body) mean mass.

    Measured: 7 weeks

  4. Muscle function

    Vertical jump height will assess 3 maximal countermovement attempts on a jump mat (Just Jump Technologies, Huntsville, AL, USA) that measures jump height based on flight time.

    Measured: 7 weeks

Secondary outcomes (1)
  1. Muscle soreness

    local muscle soreness will be assessed throughout the duration of the intervention period using a Wagner force algometer.

    Measured: 7 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2021
  2. Study start30 Mar 2024 (estimated)
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Why it stopped: A key faculty at our college who was helping with the project left the college.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two group, randomized parallel group design.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04977804
Sponsor's protocol ID
12042b
Status last verified
Nov 2023
First submitted
20 Jul 2021
Last updated
7 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Eccentric plus blood-flow restriction in people with Blood Flow Restriction, run by Utah State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 7 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eccentron maximal muscle strength (time frame: 7 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in